Roche's Rituxan wins rare-disorder indications; SciClone buys China's NovaMed for up to $104M;

@FiercePharma: U.S. drug spending grows at anemic 2.3% in 2010. News | Follow @FiercePharma

> Roche's Rituxan drug won FDA approval as a treatment for Wegener's granulomatosis and microscopic polyangilitis, two rare disorders that cause blood vessel inflammation. News

> SciClone Pharmaceuticals bought the Chinese drugmaker NovaMed Pharmaceuticals for $24.7 million in cash, plus $37.1 million in common stock, with an additional $43 million cash payable if financial targets are met. Item

> FDA has approved Taro Pharmaceutical's Imiquimod cream, a generic version of Graceway Pharmaceuticals' Aldara treatment for actinic keratosis and external genital warts. Article

> Sagent Pharmaceuticals increased the size of its initial public offering to 5.75 million shares of common stock at a price of $16 per share. Report

> Biogen Idec won a positive recommendation from European regulators for a new self-administered form of its Avonex multiple sclerosis treatment, dubbed the "Avonex Pen." Story

> A series of new deals with licensees in a wide range of emerging markets has set the stage for expanded sales of Teijin Pharma's novel gout drug febuxostat. Report

> An Ohio woman has sued AstraZeneca, alleging that she suffered bone deterioration and broken bones because of hidden risks with the drugmaker's acid reflux treatment Nexium. Gibson Law Firm release

> A UK chemist chain is now offering Viagra to customers without the need for a prescription. News

> The Czech Republic's State Institute for Drug Control approved the cannabis-derived medicine Sativex, produced by UK drugmaker GW Pharmaceuticals, as a treatment for symptoms of multiple sclerosis. Report

Biotech News

 @FierceBiotech: Novartis yanks European app for Cox-2 pain drug. News | Follow @FierceBiotech

 @JohnCFierce: Novartis' Ph3 success advances blockbuster COPD program. Item | Follow @JohnCFierce

> NicOx shares pummeled after EU panel rejects naproxcinod. Story 

> Gilead inks pact on experimental RSV treatment. News 

> Bluebird's gene therapy song attracts $30M venture round. Article 

> Sangart raises $50M to fund critical Ph2b ischemia study. Item 

Drug Delivery News

> EU gives consortium $1.6M for ultrasound-triggered drug delivery. News

> Novartis has big plans for SmartPills. Report

> Polysaccharides offer a sweet way to deliver arthritis meds. Story

> Injectable gel promises on-demand, long-term delivery of arthritis medication. Item

>  DNA origami unfolding for drug delivery. Report 

> Simple electrical on/off switch controls drug-delivering membrane. Article 

Medical Device News

> Roche gets FDA OK for HPV test. Story

> St. Jude's Q1 results beat expectations. Item 

> Stryker sees profit slip as sales rise. News 

> Neoprobe's largest investor to drop proxy fight threat. Article 

> Medtronic introduces new product for drawing bone marrow. Story

> Anulex sees layoffs after FDA warning letter. Report

And Finally... A new product, dubbed "Viagra for condoms," is nearing regulatory approval and could be on sale in Europe by the end of the year. News